Cleared Special

K132338 - DA01 BLOOD GLUCOSE MONITORING SYSTEM

K132338 is an FDA 510(k) clearance for DA01 BLOOD GLUCOSE MONITORING SYSTEM, manufactured by Delbio Incorporation. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 90-day FDA review.

K132338 · Delbio Incorporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
90d
Days
Class 2
Risk

K132338 is an FDA 510(k) clearance for the DA01 BLOOD GLUCOSE MONITORING SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Delbio Incorporation (Taoyuan County, TW). The FDA issued a Cleared decision on October 24, 2013 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K132338

510(k) Number K132338 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2013
Decision Date October 24, 2013
Days to Decision 90 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 88d · This submission: 90d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 510
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K132338.
AGAMATRIX HEALTH MANAGER
K132821 · Agamatrix, Inc. · Nov 2013
UNISTRIP 1
K113135 · Unistrip Technologies, LLC · Nov 2013
PREFERRED BLOOD GLUCOSE MONITORING SYSTEM
K122338 · Prodigy Diabetes Care, LLC · Nov 2013
FOCUS BLOOD GLUCOSE MONITORING SYSTEM, FOCUS PRO BLOOD GLUCOSE MONITORING SYSTEM
K131013 · Nova Biomedical Corporation · Oct 2013
GLOOKO DEVICE SYSTEM FOR GLOOKO APPLICATION
K132272 · Glooko, Inc. · Oct 2013
CONTOUR NEXT LINK WIRELESS BLOOD GLUCOSE MONITOR
K122370 · Bayer Healthcare · Sep 2013